What is Pacira BioSciences Price-to-Operating-Cash-Flow?
As of today (2024-05-08), Pacira BioSciences's share price is €24.60.
Pacira BioSciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €3.18. Hence, Pacira BioSciences's Price-to-Operating-Cash-Flow Ratio for today is 7.75.
The historical rank and industry rank for Pacira BioSciences's Price-to-Operating-Cash-Flow or its related term are showing as below:
FRA:82P'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.9 Med: 39.14 Max: 894.45
Current: 7.98
During the past 13 years, Pacira BioSciences's highest Price-to-Operating-Cash-Flow Ratio was 894.45. The lowest was 7.90. And the median was 39.14.
Pacira BioSciences's Cash Flow from Operations per share for the
three
months ended in Mar. 2024 was €0.97.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was €3.18.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Pacira BioSciences was 17.30% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 19.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 21.60% per year.
During the past 13 years, Pacira BioSciences's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.60% per year. The lowest was -16.00% per year. And the median was 23.10% per year.
Pacira BioSciences Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Pacira BioSciences's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pacira BioSciences Price-to-Operating-Cash-Flow Chart
|
Pacira BioSciences Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
26.66 |
33.94 |
21.84 |
12.37 |
11.34 |
|
Pacira BioSciences Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
14.42 |
12.93 |
10.16 |
11.34 |
8.80 |
Competitive Comparison of Pacira BioSciences's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacira BioSciences's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Pacira BioSciences's Price-to-Operating-Cash-Flow falls into.
Pacira BioSciences Price-to-Operating-Cash-Flow Calculation
Pacira BioSciences's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 24.60 | / | 3.176 |
| = | 7.75 |
Pacira BioSciences's Share Price of today is €24.60.
Pacira BioSciences's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Pacira BioSciences (FRA:82P) Business Description
Traded in Other Exchanges
Address
5401 West Kennedy Boulevard, Suite 890, Tampa, FL, USA, 33609
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.
Pacira BioSciences (FRA:82P) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:82P has been successfully added to your